Borosil share price is currently trading at around ₹237.05, down 2.84% today. The stock remains nearly 42% below its 52-week high of ₹397.95, while staying above its 52-week low of ₹213.73. Over the past year, the stock has declined by roughly 27–31%.
However, the recent weakness does not tell the complete story. FY26 revenue grew 8% to ₹1,195.9 Cr, but the headline growth was affected by disruption in the vacuum-insulated steel flask business, Hydra. The segment saw a 30% degrowth after a BIS quality-control order disrupted import-based supply, affecting around ₹100 Cr of Hydra sales and giving competitors with local manufacturing capabilities an opportunity to gain shelf space.
What makes Borosil’s FY26 story particularly important for investors is the gap between management’s earlier guidance and actual execution. Borosil’s investor-relations page provides the Q3 FY26 and Q4 FY26 earnings-call transcripts, making it possible to compare what management promised in February with what was delivered by May.
So, the key question for investors tracking Borosil share price is:
Is the current weakness a temporary disruption before Hydra and solar capacity ramp up, or does it point to deeper execution and profitability concerns?
In this article, we analyse Borosil’s business, compare management’s promises with actual delivery, review FY26 fundamentals, examine the technical setup and assess the key factors that could influence Borosil share price going forward.
Why Is Borosil Share Price in Focus?
Several developments have kept Borosil in focus. While the stock remains under pressure, its core glassware business continues to show growth, while the company is also investing in new capacity and infrastructure that could support its next phase of growth.
Key Investment Triggers
Hydra Supply Disruption, Not Just a Demand Problem
A BIS quality-control order disrupted Borosil’s import-based Hydra flask supply, resulting in a 30% decline in the segment and an estimated ₹100 Cr revenue impact. Management has indicated that the underlying demand for the category remained strong, making the planned domestic manufacturing capacity an important trigger to watch.
Margin and Project Timelines Remain Key Watchpoints
FY26 EBITDA margin came in at 15.1%, compared with 16.3% in the previous year and below management’s earlier near-term expectation of margins moving into the low-20% range. The commissioning timelines for both the Hydra and solar projects also moved beyond the earlier timelines.
Balance Sheet Moved From Net Cash to Net Debt
Borosil’s balance sheet moved from a net cash position of around ₹13 Cr in December 2025 to net debt of ₹49.7 Cr by March 2026. The change reflects the company’s investment cycle and increased working-capital requirements.
China Import Pricing Pressure Remains a Key Risk
Management has highlighted pricing pressure from Chinese imports and acknowledged that the expected manufacturing-cost advantage has not yet fully materialised. An anti-dumping duty investigation is also pending.
Major Capex Programme Is Underway
Borosil is investing across several areas, including a new Hydra flask facility in Rajasthan, a Bharuch glassware facility, furnace-capacity expansion and a 20 MWp solar plant. FY27 capex has been guided at around ₹110 Cr.
Borosil Share Price Is Consolidating Near ₹230–240
From a technical perspective, Borosil share price is consolidating within a contracting range around the ₹230–240 zone. The broader weekly trend remains weak, with the stock trading below its major moving averages.
What Should Investors Watch Next?
The next few quarters could be particularly important for Borosil. Investors should track three things closely: Hydra capacity commissioning and ramp-up, progress on the solar project, and whether EBITDA margins begin moving back towards management’s longer-term targets.
The company’s FY26 performance showed that its core glassware business remains capable of growth, but the full growth potential will depend on how effectively Borosil resolves the Hydra supply disruption, manages costs and converts its ongoing capex into higher revenue and profitability.
This makes the management promises-versus-delivery scorecard particularly useful. Rather than relying only on fresh guidance, investors can compare each new target with actual quarterly execution.
About Borosil Ltd
Borosil Limited, incorporated in 2010 (as Hopewell Tableware Private Limited) and headquartered in Mumbai, is one of India’s leading consumer and scientific glassware manufacturers, with operations extending to India, Europe, the Middle East and the USA.
Business Segments
Borosil’s growth strategy rests on riding India’s broader “plastic-to-glass” shift in consumer kitchenware while building out adjacent categories like insulated flasks and opalware a strategy that FY26 showed is working well in glassware itself, but which remains genuinely exposed to regulatory and import-related supply shocks in newer categories like Hydra.
Management Promises vs. Delivery: The Q3-to-Q4 Scorecard
One thing that sets this analysis apart is that Borosil’s own management gave investors an unusually direct way to check its credibility by comparing what was promised on the Q3 FY26 earnings call (February 6) against what was actually delivered by the Q4 FY26 call (May 22).
|
Q3 Call · Feb 6 What Was Promised |
Q4 Call · May 22 What Actually Happened |
|---|---|
| Hydra plant: 2 lines commercial by end of Q4 FY26 (March). | Slipped: “Next few days before end of Q1 FY27” — about a quarter late. |
| Third Hydra line: End of Q1 FY27. | Pushed further: End of Q2 FY27. |
| Solar plant: Commissioning “this month, Q4 FY26”. | Slipped: Expected to be commissioned in Q1 FY27. |
| EBITDA margin: Guided to “low-20s in the very short foreseeable future”; management said it “would have been closer to 18%+ without the Hydra issue”. | FY26 margin: 15.1%. Down from 16.3% the year before — a clear miss versus the company’s stated near-term floor. |
| Balance sheet: Net cash of ~₹13 Cr as of December 2025. | Swung to net debt of ₹49.7 Cr by March 2026 — implying a ₹60+ Cr increase in net debt within one quarter. |
Investor Takeaway: Management is genuinely executing on the strategic actions it committed to the plants are being built, the solar project is real but its own timelines and margin guidance have slipped twice within a single quarter. To its credit, management was candid about both the delays and the miss rather than obscuring them, which is a mild credibility positive even as the numbers themselves disappoint. The next two quarters, when the delayed Hydra and solar capacity are actually supposed to go live, are the real test of whether stated intent converts into delivered numbers.
Fundamental Analysis of Borosil
1. Sales Growth Is Real, But Has a Hidden Crack: Hydra
FY26 revenue grew 8% to ₹1,195.9 Cr, but this growth was suppressed rather than fully organic the Hydra flask business saw a 30% degrowth driven entirely by the BIS quality-control order, not falling demand, costing an estimated ₹100 Cr in sales and permanent shelf space to competitors with ready local manufacturing.
Investor Takeaway: The headline 8% growth understates the underlying strength of Borosil’s core business but it also means FY26 doesn’t cleanly show what Borosil’s real growth potential looks like once the Hydra supply issue is resolved.
2. Segment Mix Glassware Is the Star, Opalware Is Stalling
Glassware grew 17.3% in FY26, the strongest performer, riding India’s plastic-to-glass shift. Larah Opalware grew a slower 7.3%, with management openly describing the category as “not exciting” and running near 90–95% utilization, needing a product refresh with no major capex currently planned. Non-glassware grew just 2.4%, entirely dragged down by the Hydra crisis.
Investor Takeaway: Glassware’s strength is the clearest positive in the FY26 numbers, while Opalware needs a genuine product refresh not just capacity to reignite growth.
3. Capacity Expansion Real Capex, Real Projects Underway
Borosil is investing in a Stylenest India (Rajasthan) facility for Hydra flasks (~₹65 Cr, 3 production lines, ~4 million units/year), a Bharuch glassware facility via Borosil Scientific (~₹42 Cr, targeted Q3 FY27), furnace capacity expansion from 25 to 32 TPD (~₹50 Cr, FY27/28), and a 20 MWp solar plus battery storage plant (₹75 Cr, expected to cover 61–65% of total power needs). Total FY27 capex is guided at around ₹110 Cr, funded through a mix of debt, equity and internal accruals.
Investor Takeaway: This is a genuine, multi-pronged investment cycle rather than a single bet but as the promises-vs-delivery scorecard shows, execution timelines have already slipped once, so investors should track quarterly progress rather than assume these dates hold.
4. New Red Flag China Dumping Is Structurally Unresolved
Management confirmed directly on the earnings call that Chinese competitors routinely sell below cost of production, that Borosil’s own manufacturing investment hasn’t yet delivered the cost edge it expected, and that an anti-dumping duty investigation is pending with a 6–9 month timeline and no guaranteed outcome.
Investor Takeaway: This is a structural, not one-off, margin risk Borosil’s domestic manufacturing advantage is currently being offset by import pricing pressure, and resolution depends on a regulatory process outside the company’s control.
5. Other Confirmed and Quantified Red Flags
Gas costs for furnaces jumped 2.5x, from ₹20 Cr to ₹50 Cr a year, due to the West Asia crisis a direct, unhedged margin hit. Management also confirmed it is deliberately stockpiling appliance inventory ahead of the October 2026 BIS/QCO deadline, which explains rising working-capital days but ties up cash further if demand disappoints. Additionally, FY26 PAT of ₹74.7 Cr included a reversed demerger expense (+₹7.2 Cr) and royalty income (₹12 Cr) stripping these one-time items out shows underlying profitability is weaker than the headline “flat YoY” PAT suggests.
Investor Takeaway: Several distinct pressures energy costs, deliberate inventory build, and one-time items propping up reported profit are compounding at the same time, making FY26’s headline numbers less representative of the underlying run-rate than they first appear.
6. Shareholding FII Gap Openly Acknowledged by Management
Promoter holding fell from 70.2% in September 2023 to 64.68% by June 2026. Notably, when directly challenged on an earnings call about why FII holding remains stuck below 1% despite Borosil being a household brand, the CEO candidly responded that the company controls performance, not its stock price, and that it likely needs to cross ~₹2,000 Cr in revenue (versus ~₹1,200 Cr currently) before larger institutional investors take notice.
Investor Takeaway: This is a rare instance of management openly acknowledging a real structural limitation rather than deflecting a mild credibility positive, even though the underlying issue (low institutional ownership) remains unresolved.
7. Valuation Still Looks Rich Relative to Delivered Performance
Borosil trades at a P/E of around 36.9x against an industry median of roughly 26.9x, a P/B of about 3.25x, and ROE of just 9.16%. Independent intrinsic value estimates of around ₹134 (versus a CMP in the ₹232–237 range) look more justified in light of the confirmed guidance misses.
Investor Takeaway: The stock’s premium valuation was arguably harder to defend even before FY26’s misses now that margin and timeline guidance have both slipped, that premium needs to be reassessed against delivered, not promised, performance.
8. Long-Term Track Record Still Intact If You Trust It
FY18–FY26 revenue grew at a 21.4% CAGR with EBITDA growing faster at 29.4%. Larah grew from ₹48 Cr to ₹412 Cr (24% CAGR) since acquisition, and non-glassware scaled from ₹23 Cr to ₹464 Cr (39.6% CAGR). Management closed the Q4 call reiterating the same medium-term targets 15–20% revenue growth and 20%+ EBITDA margins despite the year’s shortfall.
Investor Takeaway: The multi-year track record is genuinely strong, and management’s continued confidence could reflect either real conviction or optimism bias only the next 1–2 quarters, once the delayed Hydra and solar plants actually ramp, will clarify which.
Key Positives
Glassware segment grew 17.3% in FY26, riding a genuine structural consumer shift.
Multi-pronged capex program covering the Hydra plant, solar and furnace expansion is real and underway.
Management has been unusually transparent about both project delays and margin misses.
FY18–FY26 revenue CAGR of 21.4%, with EBITDA growing even faster at 29.4%.
Larah Opalware and non-glassware businesses have both scaled significantly since acquisition/launch.
Key Risks Investors Should Monitor
FY26 EBITDA margin of 15.1% missed management’s own “low-20s” guidance.
Hydra and solar plant commissioning both slipped by a quarter or more.
Balance sheet swung from net cash to ~₹49.7 Cr net debt in one quarter.
China dumping remains a structural and unresolved margin risk.
Gas costs more than doubled due to the West Asia crisis.
FY26 PAT included one-time items, masking weaker underlying profitability.
Valuation remains rich at ~37x P/E relative to delivered performance and 9.16% ROE.
Technical Analysis of Borosil Share Price
From a technical standpoint, Borosil’s weekly chart shows a stock still under a long-term downtrend, consolidating within a well-defined range while it waits for a decisive move in either direction.
Long-Term Trend Is Still Bearish
The stock has been making lower highs since its 2024–25 peak of over ₹500, with a descending trendline still intact the broader trend cannot be called bullish until this trendline is decisively broken.
A Triangle Is Forming Near ₹230–240
Recent price action shows the stock consolidating within a contracting range, with a lower trendline providing support and the falling upper trendline capping the upside. A breakout above ₹264 would be a bullish confirmation, while a breakdown below ₹207 would confirm bearish continuation.
₹264 Is the Immediate Resistance
This level sits close to both the falling trendline and the stock’s recent rejection area. A weekly close above ₹264 with strong volume would indicate buyers are starting to take control.
The 50-Week Moving Average at ₹272 Is the Next Hurdle
Even if the stock clears ₹264, it would immediately face the 50-week moving average around ₹271.98. The stronger bullish confirmation sequence would be a ₹264 breakout followed by a sustained move above ₹272 until then, any rally should be treated as a recovery attempt rather than a confirmed trend reversal.
The Stock Sits Below All Major Moving Averages
With the stock at ₹237, it remains below the 50-WMA (₹272), 100-WMA (₹322) and 200-WMA (₹298) a negative long-term structure. A sustained move above the 200-WMA in particular would be a much stronger signal that the long-term trend is genuinely changing.
₹207–210 Is the Crucial Support Zone
This is the level bulls need to defend if the stock holds ₹207–210 and forms higher lows, the current consolidation could eventually resolve into an upside breakout. A weekly close below ₹207 would be a significant technical breakdown and could open the door to further downside.
RSI at 45.92 Is Neutral
RSI below 50 indicates bullish momentum hasn’t yet taken control, though the stock isn’t overbought or oversold either. A move above 50 would signal improving momentum, with 55–65 indicating a genuinely stronger bullish trend.
Volume Needs to Improve for a Genuine Breakout
Current volume is around 197.77K for a triangle/trendline breakout to be reliable, price action needs to be accompanied by significantly higher volume; a ₹264 crossover on weak volume risks becoming a false breakout.
Upside Levels After a Successful Breakout
A convincing weekly close above ₹264–272 would open the path to ₹298 (≈200-WMA), then ₹321 (≈100-WMA), then ₹330+ (major historical/technical resistance) a move above ₹322–330 would substantially improve the long-term technical picture.
Key Support Levels
| Support Level | Why It Matters |
|---|---|
| ₹207–210 | Crucial support; bulls must defend this zone. |
Key Resistance / Upside Targets
| Resistance / Target | Significance |
|---|---|
| ₹264 | Immediate resistance / breakout trigger. |
| ₹272 | 50-week moving average, stronger confirmation level. |
| ₹298 | 200-week moving average. |
| ₹321–330+ | 100-week moving average and major historical resistance. |
Should Investors Consider Borosil Share Price at Current Levels?
Borosil’s FY26 story is genuinely more complex than the headline 8% revenue growth suggests a regulatory supply shock to its Hydra business, compounded by an external energy-cost shock, masks real strength in its core glassware segment. Management’s transparency about both the delays and the margin miss is a credibility positive, and the ongoing capex program shows real commitment to the growth plan.
At the same time, the pattern of slipped timelines and missed margin guidance means investors shouldn’t take the next set of targets at face value without verification, and the valuation still looks rich relative to what’s actually been delivered so far. From a technical perspective, the stock remains below all its major moving averages inside a well-defined ₹207–264 range a decisive, volume-backed close above ₹264 and then ₹272 would be needed before the chart can be read as constructive again.
Final Thoughts
Borosil’s FY26 was a year where a genuinely strong core business (glassware, up 17.3%) was masked by a self-inflicted regulatory gap (the Hydra/BIS issue) and an external shock (gas costs). The real test now is whether the delayed Hydra and solar capacity actually go live on the newly revised timelines, and whether management’s reiterated 15–20% growth and 20%+ EBITDA margin targets hold up better than the previous set did.
Investors would do well to track the next two quarters closely against the specific dates management has now given, rather than taking fresh guidance at face value given the recent slippage the promises-vs-delivery scorecard above is exactly the kind of comparison worth repeating each quarter. This is another area where AI in investing is genuinely useful stock market AI tools can flag guidance-versus-delivery gaps like this automatically by comparing management commentary across consecutive earnings calls, rather than requiring investors to manually cross-reference transcripts every quarter.
